MedNet.nl: Alirocumab every 2 or 4 weeks is a safe and effective treatment in children and adolescents with heterozygous familial hypercholesterolemia that cannot be controlled with statins. It lowers LDL cholesterol and other pro-atherogenic lipid parameters.
05-09-2023 | Hypercholesterolemia | News
ESC 2023